In the ever changing biotherapeutics landscape, antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) success hinges on more than simply antigen recognition. While the Fab region controls ...

This article and associated images are based on a poster originally authored by Nikita Kathuria, Annabelle Herrington-Symes, Elisha Moran, Han Yin, Kathryn Armour, Michael Marshall, Nathan Robertson ...